Free Trial

Cantor Fitzgerald Weighs in on Enovix FY2025 Earnings

Enovix logo with Oils/Energy background

Enovix Co. (NASDAQ:ENVX - Free Report) - Equities researchers at Cantor Fitzgerald issued their FY2025 earnings per share (EPS) estimates for Enovix in a report issued on Tuesday, January 21st. Cantor Fitzgerald analyst D. Soderberg forecasts that the company will post earnings of ($1.18) per share for the year. Cantor Fitzgerald currently has a "Overweight" rating and a $30.00 target price on the stock. The consensus estimate for Enovix's current full-year earnings is ($1.17) per share.

Enovix (NASDAQ:ENVX - Get Free Report) last announced its earnings results on Tuesday, October 29th. The company reported ($0.17) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.20) by $0.03. The company had revenue of $4.30 million for the quarter, compared to analysts' expectations of $4.11 million. Enovix had a negative net margin of 1,180.21% and a negative return on equity of 102.19%. During the same quarter in the previous year, the company posted ($0.27) EPS.

A number of other research firms have also issued reports on ENVX. JPMorgan Chase & Co. dropped their price target on Enovix from $18.00 to $15.00 and set an "overweight" rating for the company in a research report on Tuesday, October 22nd. Benchmark reaffirmed a "buy" rating and issued a $25.00 target price on shares of Enovix in a research note on Wednesday, October 30th. Finally, Janney Montgomery Scott cut shares of Enovix from a "buy" rating to a "neutral" rating and set a $10.00 price target on the stock. in a research report on Thursday, October 31st. Two research analysts have rated the stock with a hold rating, eight have issued a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and an average price target of $20.50.

Check Out Our Latest Stock Report on ENVX

Enovix Price Performance

NASDAQ ENVX traded up $0.67 during trading hours on Thursday, hitting $12.11. 7,533,677 shares of the company's stock traded hands, compared to its average volume of 8,349,822. The company has a debt-to-equity ratio of 0.99, a current ratio of 3.77 and a quick ratio of 3.61. The firm's 50-day moving average is $10.16 and its 200-day moving average is $10.88. Enovix has a 52-week low of $5.70 and a 52-week high of $18.68. The company has a market capitalization of $2.16 billion, a PE ratio of -7.52 and a beta of 1.86.

Hedge Funds Weigh In On Enovix

Hedge funds have recently modified their holdings of the business. Mercer Global Advisors Inc. ADV purchased a new stake in Enovix during the 2nd quarter valued at approximately $163,000. Sei Investments Co. purchased a new stake in shares of Enovix during the second quarter worth approximately $555,000. Fred Alger Management LLC acquired a new stake in shares of Enovix during the second quarter worth $354,000. Delta Investment Management LLC purchased a new position in Enovix in the 2nd quarter valued at $155,000. Finally, The Manufacturers Life Insurance Company increased its stake in Enovix by 8.2% in the 2nd quarter. The Manufacturers Life Insurance Company now owns 85,403 shares of the company's stock valued at $1,320,000 after buying an additional 6,484 shares during the period. 50.92% of the stock is currently owned by hedge funds and other institutional investors.

Insiders Place Their Bets

In related news, Director Betsy S. Atkins sold 75,000 shares of Enovix stock in a transaction on Tuesday, December 3rd. The shares were sold at an average price of $9.73, for a total transaction of $729,750.00. Following the sale, the director now directly owns 99,497 shares in the company, valued at $968,105.81. This trade represents a 42.98 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. 15.70% of the stock is owned by company insiders.

Enovix Company Profile

(Get Free Report)

Enovix Corporation designs, develops, and manufactures lithium-ion batteries. It serves wearables and IoT, smartphone, laptops and tablets, industrial and medical, and electric vehicles industries. The company was founded in 2007 and is headquartered in Fremont, California.

Recommended Stories

Should You Invest $1,000 in Enovix Right Now?

Before you consider Enovix, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Enovix wasn't on the list.

While Enovix currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio?

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Palantir’s Explosive Growth: Buy Now or Wait for a Dip?
5 Stocks to BUY NOW in February 2025
How To Invest in Crypto as A Complete BEGINNER in 2025

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines